Medherant said today that it was awarded a Medicines Manufacturing Grant from Innovate UK to support the manufacturing of transdermal drug-delivery patches.
The company plans to expand its pilot-scale GMP manufacturing program, which is designed to make patches formulated with its Tepi patch tech for clinical trials.
Get the full story at our sister site, Drug Delivery Business News.
The post Medherant wins grant to support manufacturing program for transdermal drug-delivery patches appeared first on MassDevice.